Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2010
09/29/2010CN101843814A Chinese medicinal compound preparation for treating gout and hyperuricemia and preparation method thereof
09/29/2010CN101843812A Bone-knitting qili compound and preparation method thereof
09/29/2010CN101843811A Oral preparation special for treating gout
09/29/2010CN101843810A Medicinal liquor for treating bi syndromes and preparation method thereof
09/29/2010CN101843801A Bone permeable blood-activating and pain-relieving tincture
09/29/2010CN101843799A Oral Chinese medicament for treating fracture
09/29/2010CN101843798A Oral Chinese medicament for treating fracture
09/29/2010CN101843795A Yang-warming and dampness-removing Chinese medicinal composition formula and preparation method thereof
09/29/2010CN101843789A Chinese medicament for treating gout
09/29/2010CN101843776A Oral Chinese medicament for treating fracture
09/29/2010CN101843769A Medicament for treating systemic sclerosis and preparation method thereof
09/29/2010CN101843764A Oral preparation special for treating lumbar vertebra disease
09/29/2010CN101843759A Oral Chinese medicament for treating fracture
09/29/2010CN101843754A Chinese medicament for treating gout
09/29/2010CN101843749A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843747A Chinese medicament for treating rheumatoid arthritis
09/29/2010CN101843746A Chinese medicament for treating cervical spondylosis
09/29/2010CN101843741A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843739A Oral Chinese medicament for treating fracture
09/29/2010CN101843731A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843729A Chinese medicament for treating cervical spondylosis
09/29/2010CN101843724A Chinese medicament for treating gout
09/29/2010CN101843718A Chinese medicament for treating lupus erythematosus
09/29/2010CN101843716A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843714A Chinese medicament for treating gout
09/29/2010CN101843710A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843708A Chinese medicament for treating cervical spondylosis
09/29/2010CN101843705A Chinese medicament for treating lupus erythematosus
09/29/2010CN101843701A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843698A Chinese medicament for treating cervical spondylosis
09/29/2010CN101843691A Chinese medicament for treating femoral head necrosis
09/29/2010CN101843690A Chinese medicament for treating osteoporosis
09/29/2010CN101843680A Application of composite containing polygonum orientale in preventing and treating climacteric diseases and delaying aging
09/29/2010CN101843679A Chinese medicament for treating cervical spondylosis
09/29/2010CN101843668A Chinese medicinal granules for treating femoral head necrosis and preparation method thereof
09/29/2010CN101843664A Sake drug for treating rheumatism
09/29/2010CN101843652A Moleplant seed composite essential oil
09/29/2010CN101843630A Composite containing iridoid compound and application thereof
09/29/2010CN101843629A New application of icariin and epimedium flavone containing icariin
09/29/2010CN101843609A Medicament for use in connection with cartilage impairment
09/29/2010CN101342228B Quick-effective bone-knitting medicament
09/29/2010CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease
09/29/2010CN101259222B Medicaments for treating bone fracture bone fracture disease
09/29/2010CN101249182B Medicament for curing lumbar pipe stenosis
09/29/2010CN101204375B Strontium ranelate dry suspension
09/29/2010CN101181369B Compound prescription for curing osteoarthropathy as well as preparation technique thereof
09/29/2010CN101147800B Casein phosphopeptide cyclodextrin inclusion compound without bitter and its preparation method
09/29/2010CN101108190B Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease
09/28/2010USRE41783 Pyrrolo[2,3-D]pyrimidine compounds
09/28/2010US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate
09/28/2010US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors
09/28/2010US7803806 protein kinase inhibitors such as 1-{3-[4-(5-Bromo-thiophen-2-yl)-pyrimidin-2-ylamino]-phenyl}-ethanol, used for the treatment of breast cancer or rheumatoid arthritis
09/28/2010US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents
09/28/2010US7803562 Method for screening human intestinal Npt2B modulatory agents
09/28/2010CA2562992C Probucol analogues, and use thereof as anti-inflammatory inhibitors of vcam-1
09/28/2010CA2481707C Benzopyran derivatives substituted with secondary amines having tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/28/2010CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
09/28/2010CA2285746C Osteoprotegerin binding proteins and receptors
09/23/2010WO2010107969A1 Improved chemical synthesis of diazaindoles by chichibabin cyclization
09/23/2010WO2010107225A2 Pharmaceutical composition for preventing and treating arthritis, containing sulforaphane as an effective ingredient
09/23/2010WO2010107108A1 Rheumatoid arthritis treatment agent
09/23/2010WO2010106812A1 Pharmaceutical formulation containing improved antibody molecules
09/23/2010WO2010106495A1 Sceletium extract and uses thereof
09/23/2010WO2010106494A1 Use of pharmaceutical compositions containing mesembrenone
09/23/2010WO2010106366A1 Fk506 and fk520 analogues and their pharmaceutical uses
09/23/2010WO2010105446A1 A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof
09/23/2010WO2010086736A3 Use of the combination of resveratrol with cysteine and derivatives thereof
09/23/2010WO2010079514A4 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010WO2010072774A3 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal
09/23/2010US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells
09/23/2010US20100240866 Modified gherlin peptides
09/23/2010US20100240756 Compounds for treating inflammation and pain
09/23/2010US20100240751 Methods
09/23/2010US20100240748 Tetrahydronaphthalen-2-ol derivatives
09/23/2010US20100240745 Method of treatment of inflammation in hypertensive patients
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240724 Edible Film
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240685 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists
09/23/2010US20100240682 Phophylactic or therapeutic agent for inflamatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240671 Substituted heterocyclic compounds
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240669 New compounds
09/23/2010US20100240666 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240593 Strontium-apatite cement preparation cements formed therefrom, and use thereof
09/23/2010US20100240125 Bone delivery conjugates and method of using same to target proteins to bone
09/23/2010US20100239654 Vesicular phospholipid gels comprising proteinaceous substances
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239634 Compositions and methods for promoting bone formation
09/23/2010US20100239554 Extended recombinant polypeptides and compositions comprising same
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 820